US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 3.030
  • -0.030-0.98%
Trading May 23 12:17 ET
293.78MMarket Cap-2589P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
60.18%-15.14M
-244.27%-92.17M
-1,296.17%-28.74M
-87.25%7.89M
16.17%-33.31M
25.95%-38.01M
73.89%-26.77M
-71.64%2.4M
251.39%61.88M
-27.80%-39.73M
Net income from continuing operations
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
265.97%70.41M
5.84%-43.04M
Operating gains losses
----
-99.14%3K
--0
--0
----
----
17,500.00%348K
2,960.00%143K
--0
----
Depreciation and amortization
4.23%1.38M
8.55%5.61M
6.13%1.44M
6.96%1.44M
11.75%1.41M
9.69%1.32M
13.62%5.17M
14.54%1.36M
15.48%1.35M
11.70%1.26M
Other non cash items
17.24%-1.63M
-4.27%808K
847.28%6.45M
69.82%-1.76M
14.61%-1.92M
-123.86%-1.97M
32.08%844K
339.35%681K
-3,936.84%-5.83M
-1,468.90%-2.25M
Change In working capital
166.76%4M
2.67%14.08M
-125.88%-7.96M
566.69%38.86M
-843.16%-10.82M
20.91%-6M
-32.00%13.72M
45.93%30.77M
-111.48%-8.33M
-113.47%-1.15M
-Change in receivables
-564.00%-3.02M
100.85%77K
-101.15%-338K
108.46%3.23M
-1,394.83%-3.47M
--650K
---9.09M
--29.38M
---38.24M
---232K
-Change in prepaid assets
-144.90%-854K
213.63%1.57M
-104.54%-31K
-34.14%-1.61M
-22.51%1.31M
385.16%1.9M
118.79%499K
221.96%683K
68.63%-1.2M
79.15%1.68M
-Change in payables and accrued expense
10.11%-5.92M
212.96%6.04M
381.89%8.3M
341.57%2.44M
6,196.67%1.89M
-8.06%-6.59M
-180.58%-5.35M
-69.57%1.72M
-1,668.42%-1.01M
-99.62%30K
-Change in other current assets
-0.68%871K
-36.01%3.33M
-15.17%850K
-39.75%805K
-34.48%802K
-46.78%877K
-5.91%5.21M
-67.32%1M
54.99%1.34M
84.89%1.22M
-Change in other current liabilities
-2.99%-963K
24.38%-3.67M
11.27%-937K
34.03%-909K
35.88%-888K
9.49%-935K
-55.86%-4.85M
-24.97%-1.06M
-50.93%-1.38M
-54.58%-1.39M
-Change in other working capital
828.82%13.88M
-75.34%6.73M
-1,543.35%-15.81M
8.53%34.9M
-323.74%-10.46M
-32.75%-1.91M
98.34%27.3M
---962K
--32.16M
---2.47M
Cash from discontinued investing activities
Operating cash flow
60.18%-15.14M
-244.27%-92.17M
-1,296.17%-28.74M
-87.25%7.89M
16.17%-33.31M
25.95%-38.01M
73.89%-26.77M
-71.64%2.4M
251.39%61.88M
-27.80%-39.73M
Investing cash flow
Cash flow from continuing investing activities
643.67%24M
119.25%39.13M
155.55%47.71M
-31.68%-47.24M
153.29%43.07M
-494.21%-4.42M
-191.43%-203.33M
-43,946.15%-85.89M
-196.60%-35.87M
-232.68%-80.83M
Net PPE purchase and sale
83.42%-130K
21.63%-3.07M
-18.85%-309K
53.34%-789K
2.79%-1.18M
-5.52%-784K
-49.54%-3.91M
-33.33%-260K
-363.29%-1.69M
22.96%-1.22M
Net investment purchase and sale
764.64%24.13M
121.16%42.2M
156.08%48.02M
-35.89%-46.45M
155.59%44.26M
---3.63M
-188.63%-199.42M
---85.63M
-191.15%-34.18M
-227.38%-79.61M
Cash from discontinued investing activities
Investing cash flow
643.67%24M
119.25%39.13M
155.55%47.71M
-31.68%-47.24M
153.29%43.07M
-494.21%-4.42M
-191.43%-203.33M
-43,946.15%-85.89M
-196.60%-35.87M
-232.68%-80.83M
Financing cash flow
Cash flow from continuing financing activities
-103.63%-43K
-84.66%16.13M
0
-80.30%14.94M
0
-95.94%1.19M
4,076.29%105.16M
-75.42%58K
3,988.30%75.84M
-52.24%32K
Net issuance payments of debt
----
--0
--0
--0
----
----
--30M
--0
--0
--0
Net common stock issuance
--0
-79.62%15.35M
--0
-80.85%14.42M
--0
--928K
--75.3M
--0
--75.3M
--0
Proceeds from stock option exercised by employees
-26.99%549K
-2.60%1.28M
--0
-2.78%524K
--0
10.43%752K
-47.97%1.31M
-75.42%58K
-70.94%539K
-52.24%32K
Net other financing activities
-19.84%-592K
65.93%-494K
--0
--0
--0
65.93%-494K
---1.45M
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-103.63%-43K
-84.66%16.13M
--0
-80.30%14.94M
--0
-95.94%1.19M
4,076.29%105.16M
-75.42%58K
3,988.30%75.84M
-52.24%32K
Net cash flow
Beginning cash position
-45.35%44.47M
-60.56%81.38M
-84.53%25.5M
-20.73%49.91M
-78.12%40.14M
-60.56%81.38M
145.72%206.33M
-16.68%164.81M
-68.47%62.96M
8.07%183.49M
Current changes in cash
121.40%8.83M
70.46%-36.91M
122.74%18.97M
-123.97%-24.41M
108.10%9.77M
-80.57%-41.23M
-202.12%-124.95M
-1,079.90%-83.43M
5,511.48%101.84M
-503.12%-120.53M
End cash Position
32.76%53.3M
-45.35%44.47M
-45.35%44.47M
-84.53%25.5M
-20.73%49.91M
-78.12%40.14M
-60.56%81.38M
-60.56%81.38M
-16.68%164.81M
-68.47%62.96M
Free cash flow
60.65%-15.27M
-210.25%-95.23M
-1,455.72%-29.05M
-88.20%7.1M
15.77%-34.49M
25.50%-38.79M
70.81%-30.7M
-74.06%2.14M
245.92%60.18M
-25.34%-40.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 60.18%-15.14M-244.27%-92.17M-1,296.17%-28.74M-87.25%7.89M16.17%-33.31M25.95%-38.01M73.89%-26.77M-71.64%2.4M251.39%61.88M-27.80%-39.73M
Net income from continuing operations 37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M265.97%70.41M5.84%-43.04M
Operating gains losses -----99.14%3K--0--0--------17,500.00%348K2,960.00%143K--0----
Depreciation and amortization 4.23%1.38M8.55%5.61M6.13%1.44M6.96%1.44M11.75%1.41M9.69%1.32M13.62%5.17M14.54%1.36M15.48%1.35M11.70%1.26M
Other non cash items 17.24%-1.63M-4.27%808K847.28%6.45M69.82%-1.76M14.61%-1.92M-123.86%-1.97M32.08%844K339.35%681K-3,936.84%-5.83M-1,468.90%-2.25M
Change In working capital 166.76%4M2.67%14.08M-125.88%-7.96M566.69%38.86M-843.16%-10.82M20.91%-6M-32.00%13.72M45.93%30.77M-111.48%-8.33M-113.47%-1.15M
-Change in receivables -564.00%-3.02M100.85%77K-101.15%-338K108.46%3.23M-1,394.83%-3.47M--650K---9.09M--29.38M---38.24M---232K
-Change in prepaid assets -144.90%-854K213.63%1.57M-104.54%-31K-34.14%-1.61M-22.51%1.31M385.16%1.9M118.79%499K221.96%683K68.63%-1.2M79.15%1.68M
-Change in payables and accrued expense 10.11%-5.92M212.96%6.04M381.89%8.3M341.57%2.44M6,196.67%1.89M-8.06%-6.59M-180.58%-5.35M-69.57%1.72M-1,668.42%-1.01M-99.62%30K
-Change in other current assets -0.68%871K-36.01%3.33M-15.17%850K-39.75%805K-34.48%802K-46.78%877K-5.91%5.21M-67.32%1M54.99%1.34M84.89%1.22M
-Change in other current liabilities -2.99%-963K24.38%-3.67M11.27%-937K34.03%-909K35.88%-888K9.49%-935K-55.86%-4.85M-24.97%-1.06M-50.93%-1.38M-54.58%-1.39M
-Change in other working capital 828.82%13.88M-75.34%6.73M-1,543.35%-15.81M8.53%34.9M-323.74%-10.46M-32.75%-1.91M98.34%27.3M---962K--32.16M---2.47M
Cash from discontinued investing activities
Operating cash flow 60.18%-15.14M-244.27%-92.17M-1,296.17%-28.74M-87.25%7.89M16.17%-33.31M25.95%-38.01M73.89%-26.77M-71.64%2.4M251.39%61.88M-27.80%-39.73M
Investing cash flow
Cash flow from continuing investing activities 643.67%24M119.25%39.13M155.55%47.71M-31.68%-47.24M153.29%43.07M-494.21%-4.42M-191.43%-203.33M-43,946.15%-85.89M-196.60%-35.87M-232.68%-80.83M
Net PPE purchase and sale 83.42%-130K21.63%-3.07M-18.85%-309K53.34%-789K2.79%-1.18M-5.52%-784K-49.54%-3.91M-33.33%-260K-363.29%-1.69M22.96%-1.22M
Net investment purchase and sale 764.64%24.13M121.16%42.2M156.08%48.02M-35.89%-46.45M155.59%44.26M---3.63M-188.63%-199.42M---85.63M-191.15%-34.18M-227.38%-79.61M
Cash from discontinued investing activities
Investing cash flow 643.67%24M119.25%39.13M155.55%47.71M-31.68%-47.24M153.29%43.07M-494.21%-4.42M-191.43%-203.33M-43,946.15%-85.89M-196.60%-35.87M-232.68%-80.83M
Financing cash flow
Cash flow from continuing financing activities -103.63%-43K-84.66%16.13M0-80.30%14.94M0-95.94%1.19M4,076.29%105.16M-75.42%58K3,988.30%75.84M-52.24%32K
Net issuance payments of debt ------0--0--0----------30M--0--0--0
Net common stock issuance --0-79.62%15.35M--0-80.85%14.42M--0--928K--75.3M--0--75.3M--0
Proceeds from stock option exercised by employees -26.99%549K-2.60%1.28M--0-2.78%524K--010.43%752K-47.97%1.31M-75.42%58K-70.94%539K-52.24%32K
Net other financing activities -19.84%-592K65.93%-494K--0--0--065.93%-494K---1.45M--0--0--0
Cash from discontinued financing activities
Financing cash flow -103.63%-43K-84.66%16.13M--0-80.30%14.94M--0-95.94%1.19M4,076.29%105.16M-75.42%58K3,988.30%75.84M-52.24%32K
Net cash flow
Beginning cash position -45.35%44.47M-60.56%81.38M-84.53%25.5M-20.73%49.91M-78.12%40.14M-60.56%81.38M145.72%206.33M-16.68%164.81M-68.47%62.96M8.07%183.49M
Current changes in cash 121.40%8.83M70.46%-36.91M122.74%18.97M-123.97%-24.41M108.10%9.77M-80.57%-41.23M-202.12%-124.95M-1,079.90%-83.43M5,511.48%101.84M-503.12%-120.53M
End cash Position 32.76%53.3M-45.35%44.47M-45.35%44.47M-84.53%25.5M-20.73%49.91M-78.12%40.14M-60.56%81.38M-60.56%81.38M-16.68%164.81M-68.47%62.96M
Free cash flow 60.65%-15.27M-210.25%-95.23M-1,455.72%-29.05M-88.20%7.1M15.77%-34.49M25.50%-38.79M70.81%-30.7M-74.06%2.14M245.92%60.18M-25.34%-40.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg